Cargando…
Prevalence and type of artefact with spectral domain optical coherence tomography macular ganglion cell imaging in glaucoma surveillance
PURPOSE: The ganglion cell analysis (GCA) of the CIRRUS(TM) HD-OCT (Carl Zeiss, Meditec; Dublin, CA) provides measurement of the macular ganglion cell-inner plexiform layer (GCIPL) thickness. This study determined the frequency of scan artefacts and errors in GCIPL imaging in individuals undergoing...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281246/ https://www.ncbi.nlm.nih.gov/pubmed/30517101 http://dx.doi.org/10.1371/journal.pone.0206684 |
_version_ | 1783378807165550592 |
---|---|
author | Awadalla, Mona S. Fitzgerald, Jude Andrew, Nicholas H. Zhou, Tiger Marshall, Henry Qassim, Ayub Hassall, Mark Casson, Robert J. Graham, Stuart L. Healey, Paul R. Agar, Ashish Galanopoulos, Anna Phipps, Simon Chappell, Angela Landers, John Craig, Jamie E. |
author_facet | Awadalla, Mona S. Fitzgerald, Jude Andrew, Nicholas H. Zhou, Tiger Marshall, Henry Qassim, Ayub Hassall, Mark Casson, Robert J. Graham, Stuart L. Healey, Paul R. Agar, Ashish Galanopoulos, Anna Phipps, Simon Chappell, Angela Landers, John Craig, Jamie E. |
author_sort | Awadalla, Mona S. |
collection | PubMed |
description | PURPOSE: The ganglion cell analysis (GCA) of the CIRRUS(TM) HD-OCT (Carl Zeiss, Meditec; Dublin, CA) provides measurement of the macular ganglion cell-inner plexiform layer (GCIPL) thickness. This study determined the frequency of scan artefacts and errors in GCIPL imaging in individuals undergoing HD-OCT surveillance for glaucoma. METHOD: A total of 1439 eyes from 721 subjects enrolled in a prospective study assessing predictors of glaucoma progression underwent macular GCIPL imaging with the CIRRUS HD-OCT at recruitment. The prevalence of acquisition errors, segmentation errors, and co-morbid macular pathology was determined. RESULTS: A total of 87 (6.0%) of the 1439 scans had either acquisition errors, segmentation artefacts, or other macular pathology. The most common co-morbid macular pathology was epiretinal membrane in 2.2% of eyes. CONCLUSION: The macular GCIPL scan was artefact free in 94% of eyes. However, epiretinal membrane and high myopia can cause scan artefact and should be considered when interpreting the results. |
format | Online Article Text |
id | pubmed-6281246 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-62812462018-12-20 Prevalence and type of artefact with spectral domain optical coherence tomography macular ganglion cell imaging in glaucoma surveillance Awadalla, Mona S. Fitzgerald, Jude Andrew, Nicholas H. Zhou, Tiger Marshall, Henry Qassim, Ayub Hassall, Mark Casson, Robert J. Graham, Stuart L. Healey, Paul R. Agar, Ashish Galanopoulos, Anna Phipps, Simon Chappell, Angela Landers, John Craig, Jamie E. PLoS One Research Article PURPOSE: The ganglion cell analysis (GCA) of the CIRRUS(TM) HD-OCT (Carl Zeiss, Meditec; Dublin, CA) provides measurement of the macular ganglion cell-inner plexiform layer (GCIPL) thickness. This study determined the frequency of scan artefacts and errors in GCIPL imaging in individuals undergoing HD-OCT surveillance for glaucoma. METHOD: A total of 1439 eyes from 721 subjects enrolled in a prospective study assessing predictors of glaucoma progression underwent macular GCIPL imaging with the CIRRUS HD-OCT at recruitment. The prevalence of acquisition errors, segmentation errors, and co-morbid macular pathology was determined. RESULTS: A total of 87 (6.0%) of the 1439 scans had either acquisition errors, segmentation artefacts, or other macular pathology. The most common co-morbid macular pathology was epiretinal membrane in 2.2% of eyes. CONCLUSION: The macular GCIPL scan was artefact free in 94% of eyes. However, epiretinal membrane and high myopia can cause scan artefact and should be considered when interpreting the results. Public Library of Science 2018-12-05 /pmc/articles/PMC6281246/ /pubmed/30517101 http://dx.doi.org/10.1371/journal.pone.0206684 Text en © 2018 Awadalla et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Awadalla, Mona S. Fitzgerald, Jude Andrew, Nicholas H. Zhou, Tiger Marshall, Henry Qassim, Ayub Hassall, Mark Casson, Robert J. Graham, Stuart L. Healey, Paul R. Agar, Ashish Galanopoulos, Anna Phipps, Simon Chappell, Angela Landers, John Craig, Jamie E. Prevalence and type of artefact with spectral domain optical coherence tomography macular ganglion cell imaging in glaucoma surveillance |
title | Prevalence and type of artefact with spectral domain optical coherence tomography macular ganglion cell imaging in glaucoma surveillance |
title_full | Prevalence and type of artefact with spectral domain optical coherence tomography macular ganglion cell imaging in glaucoma surveillance |
title_fullStr | Prevalence and type of artefact with spectral domain optical coherence tomography macular ganglion cell imaging in glaucoma surveillance |
title_full_unstemmed | Prevalence and type of artefact with spectral domain optical coherence tomography macular ganglion cell imaging in glaucoma surveillance |
title_short | Prevalence and type of artefact with spectral domain optical coherence tomography macular ganglion cell imaging in glaucoma surveillance |
title_sort | prevalence and type of artefact with spectral domain optical coherence tomography macular ganglion cell imaging in glaucoma surveillance |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281246/ https://www.ncbi.nlm.nih.gov/pubmed/30517101 http://dx.doi.org/10.1371/journal.pone.0206684 |
work_keys_str_mv | AT awadallamonas prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance AT fitzgeraldjude prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance AT andrewnicholash prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance AT zhoutiger prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance AT marshallhenry prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance AT qassimayub prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance AT hassallmark prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance AT cassonrobertj prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance AT grahamstuartl prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance AT healeypaulr prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance AT agarashish prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance AT galanopoulosanna prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance AT phippssimon prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance AT chappellangela prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance AT landersjohn prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance AT craigjamiee prevalenceandtypeofartefactwithspectraldomainopticalcoherencetomographymacularganglioncellimaginginglaucomasurveillance |